InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: None

Tuesday, 01/17/2017 10:25:10 AM

Tuesday, January 17, 2017 10:25:10 AM

Post# of 203913
Did you guys catch this (my bold/italics)?

OWCP's Action Items for 2017:

During the second quarter of 2017 OWCP intends to initiate its U.S marketing program for its Psoriasis Topical Cream. At the same time, we intend to begin investigating the applicability of topical cream for other skin conditions and disorders.
OWCP intends to proceed with the advancement of our cannabis-based treatment for multiple myeloma, with the objective of proceeding with additional studies.
OWCP intends to evaluate the launch of one or more studies to determine the applicability of cannabinoid-based pharmaceuticals for other medical conditions and disorders, such as fibromyalgia and migraines.



IMHO It's highly probable that during the testing of the psoriasis cream on some test patients an improvement of other skin conditions was noticed. Imagine if OWCP's cream can be used to treat multiple skin conditions! To the Moon! GLTA!


https://www.otcmarkets.com/stock/OWCP/news/OWC-Pharmaceutical-Research-Corp-Issues-Annual-Letter-to-Shareholders?id=148669&b=y